Join Fawkes' Crowdfunding Campaign & Become a Member of Our Community
Fawkes Biotechnology represents a rare investment opportunity at the intersection of biotechnology, point-of-care diagnostics, and the rapidly growing brain health market.
THE INVESTMENT OPPORTUNITY
Fawkes is transforming how we detect concussions.
Millions of people suffer from concussions each year. Unfortunately, due to inconvenient and unreliable testing, most of these injuries go completely undiagnosed – we’re changing that.
We’re launching a Reg CF crowdfunding campaign to bring this breakthrough technology to market. Your investment will help us transform concussion care globally and capture a significant share of the rapidly growing brain health diagnostics market.
Validation & Roadmap
We've Already Proven This Works - And We're Preparing To Make It Widely Available
Clinical Validation
Our prototype device has been validated with emergency room patients and NCAA athletes, with biomarker performance published in peer-reviewed studies.
Manufacturing Partnerships
Proprietary antibody development is underway via Labcorp, complemented by our partnership with DCN Diagnostics for GMP-ready manufacturing.
Regulatory Pathway
We’ve mapped a clear regulatory path toward FDA 510(k) submission, positioning our technology for rapid market entry.
UPCOMING MILESTONES
We're Ready to Scale, and You Can Be A Part of It
Your investment will help us take the next critical steps toward development & commercialization.
Finalize GMP Production
Scale up production with our partner DCN Diagnostics to meet commercial demand while maintaining quality standards.
Conduct Larger Clinical Trials
Validate test performance in broader patient populations across sports, military, and urgent care settings.
Prepare for FDA Submission
Complete 510(k) clearance pathway for point-of-care concussion testing to bring our solution to market.
Engage Commercial Partners
Launch pilot programs in sports, military, and urgent care settings to establish early market presence.
